Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antibacterial therapeutics - PTC Therapeutics

Next Previous
Drug Profile

Research programme: antibacterial therapeutics - PTC Therapeutics

Alternative Names: PTC 672; Ribonuclease P inhibitors research programme - PTC Therapeutics; RNase P inhibitors research programme - PTC Therapeutics

Latest Information Update: 28 Dec 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PTC Therapeutics
  • Class Small molecules
  • Mechanism of Action DNA synthesis inhibitors; Ribonuclease P inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Bacterial infections; Gonorrhoea

Most Recent Events

  • 28 Dec 2018 No recent reports of development identified for preclinical development in Gonorrhoea in USA
  • 04 Nov 2017 No recent reports of development identified for research development in Bacterial-infections in USA
  • 06 Nov 2014 Preclinical development for Gonorrhoea in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top